However, the non-negligible methylation occurring in the adjacent normal colorectal mucosa may confound the assessment of tumor-specific CDKN2A hypermethylation suggesting that corresponding non-neoplastic tissue should be used as a control. The gene discussed is CDKN2A; the disease is neoplasm.